HYFT
MINDWALK HLDG (HYFT)
NASDAQ
$1.41$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT
  • $66.3M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
04/30/2026
04/30/2025
04/30/2024
04/30/2023
Income Statement
Total Operating Revenue
15.6M
-36.55%
24.5M
+0.008%
24.5M
+18.65%
20.7M
+6.72%
Cost of Revenue
6.4M
-41.58%
11.0M
-11.98%
12.5M
+36.95%
9.1M
+8.60%
Gross Profit
9.1M
-32.48%
13.5M
+12.40%
12.1M
+4.24%
11.6M
+5.28%
Sales and Marketing Expense
5.9M
+38.18%
4.3M
+21.31%
3.5M
-1.80%
3.6M
+387.57%
Research and Development Expense
-4.9M
-0.20%
-4.9M
+22.26%
-4.0M
-67.08%
-12.3M
+83.48%
Depreciation and Amortization Expense
1.6M
-68.67%
5.1M
-10.74%
5.7M
-14.21%
6.7M
+77.37%
Total Operating Expenses
13.2M
-10.33%
14.7M
-5.50%
15.6M
-21.30%
19.8M
+1,600.60%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-13.9M
-53.86%
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
Income Taxes
-450,000
-88.84%
-4.0M
+164.29%
-1.5M
+28.02%
-1.2M
-238.44%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-13.9M
-53.86%
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
Net Income from Continuing Operations Applicable to Common
-13.9M
-53.86%
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
Basic EPS and Net Income
N/A
N/A
-0.91
-14.15%
-1.06
N/A
N/A
N/A
Diluted EPS and Net Income
-0.33
-63.74%
-0.91
-14.15%
-1.06
N/A
N/A
N/A
Basic Weighted Average Shares
46.4M
+38.93%
33.4M
+30.23%
25.6M
+2.97%
24.9M
+26.46%
Diluted Weighted Average Shares
46.4M
+38.93%
33.4M
+30.23%
25.6M
+2.97%
24.9M
+26.46%
Balance Sheet
Cash and Cash Equivalents
11.3M
+6.40%
10.7M
+208.33%
3.5M
-58.22%
8.3M
-72.37%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.3M
+6.40%
10.7M
+208.33%
3.5M
-58.22%
8.3M
-72.37%
Total Current Assets
16.2M
-13.51%
18.8M
+63.26%
11.5M
-31.59%
16.8M
-55.19%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
4.0M
-74.32%
15.8M
-5.59%
16.7M
+60.66%
10.4M
+211.32%
Total Long-Term Assets
82,000
+2.50%
80,000
-99.84%
48.5M
-20.52%
61.0M
+8.92%
Total Assets
21.4M
-51.90%
44.4M
-25.92%
60.0M
-22.91%
77.8M
-16.77%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.8M
-35.76%
9.0M
+10.93%
8.1M
+37.23%
5.9M
-36.09%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
9.6M
-53.75%
20.8M
-20.15%
26.1M
+30.27%
20.0M
+9.89%
Retained Earnings
-142.7M
+10.83%
-128.8M
+28.45%
-100.3M
+37.18%
-73.1M
+57.08%
Total Stockholders Equity
11.7M
-50.27%
23.6M
-30.35%
33.9M
-41.32%
57.8M
-23.22%
Total Shares Outstanding
46.7M
+1.21%
46.2M
+71.29%
26.9M
+7.56%
25.1M
+2.34%
Cash Flow
Cash from Operating Activities
-12.5M
+94.43%
-6.4M
+50.97%
-4.2M
-78.59%
-19.8M
+99.91%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
13.5M
+1,795.24%
-799,000
-48.88%
-1.6M
-20.54%
-2.0M
-62.23%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
115,000
-99.23%
14.9M
+1,358.67%
1.0M
+264.41%
-621,000
-121.54%
Financials Ratio
Gross Margin
58.80%
+6.42%
55.25%
+12.39%
49.16%
-12.14%
55.95%
-1.35%
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-42.39%
-26.80%
-57.90%
+46.80%
-39.44%
+27.20%
-31.01%
+48.88%
Return on Equity
-78.86%
-24.95%
-105.08%
+77.32%
-59.26%
+48.47%
-39.91%
+57.91%
Revenue Growth
-36.55%
-445,829.27%
0.008%
-99.96%
18.65%
+177.51%
6.72%
-17.12%
Current Ratio
2.80
+34.64%
2.08
+47.17%
1.41
-50.15%
2.84
-29.88%
Cash Ratio
1.96
+65.65%
1.18
+177.92%
0.43
-69.56%
1.40
-56.77%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow